Answer
Women of childbearing potential should continue effective contraception for at least 3 weeks after the final dose of elafibranor.
Sources for this answer
- Iqirvo 80 mg film-coated tabletsIpsen Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 1Document updated
Sources checked